ArticleBiomedical optics express2025
Tartrazine-enabled optical clearing for in vivo optical resolution photoacoustic microscopy.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Tartrazine clearing of the tympanic membrane for improved visualization of the middle ear.Biomedical optics express · 2026Article
- Tartrazine Clears Live Cells while Preserving Viability at High Refractive Indices and Osmolality.Bioconjugate chemistry · 2026Article
- In vivo tissue clearing with tartrazine and other dye molecules.Communications biology · 2026Review
- Introduction to the feature issue Photoacoustic Imaging and Sensing: Beyond Fundamentals to Translation.Biomedical optics express · 2026Article
- Advancing small-animal molecular imaging through multifaceted innovation.Journal of biomedical optics · 2026Article
- Tartrazine clears live cells while preserving viability at high refractive indices and osmolality.bioRxiv : the preprint server for biology · 2026Article
- Tartrazine-enhanced visible-light OCT for deep-tissue imaging.Biomedical optics express · 2026Article
- Enhancing photothermal therapy effectiveness via tartrazine-induced optical clearing of biological tissues.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Optical-resolution photoacoustic microscopy (OR-PAM) is a powerful imaging technique that visualizes microvascular and tissue structures with high spatial resolution, offering valuable insights into physiological and pathological processes. However, strong optical scattering in biological tissues fundamentally limits its imaging depth. Recent studies have suggested that tartrazine, a food-grade water-soluble dye, may serve as an effective optical clearing agent (OCA), yet its strong optical absorption near 532 nm raises concerns about compatibility with green-light-based OR-PAM systems. In this study, we demonstrate that by carefully controlling the concentration of tartrazine, it can effectively function as an OCA for OR-PAM at 532 nm without compromising signal quality. In vivo experiments on mouse ear and abdominal tissue showed that tartrazine significantly enhanced microvascular visibility across all tested concentrations, with the 15% weight of solute per weight of solution providing optimal clearing performance. Additionally, we evaluated 4-aminoantipyrine as another dye-based OCA, which also improved image clarity, albeit to a lesser extent. These findings highlight the promise of absorbing dye-based OCAs like tartrazine in enhancing in vivo OR-PAM by mitigating light scattering, potentially enabling deeper and clearer photoacoustic imaging in biomedical applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.